-0.67%
9.34%
10.61%
2.30%
39.54%
-1.91%
-28.97%
AI Spotlight on PHIA
Company Description
Koninklijke Philips N.V. operates as a health technology company in North America and internationally.It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments.The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services.
It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions.In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions.It has a strategic collaboration with Ibex Medical Analytics Ltd.
to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB.The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013.Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Market Data
| Last Price | 26.68 |
| Change Percentage | -0.67% |
| Open | 26.75 |
| Previous Close | 26.86 |
| Market Cap ( Millions) | 24922 |
| Volume | 1107953 |
| Year High | 30.22 |
| Year Low | 17.49 |
| M A 50 | 24.95 |
| M A 200 | 25.61 |
Financial Ratios
| FCF Yield | 1.10% |
| Dividend Yield | 3.19% |
| ROE | -2.74% |
| Debt / Equity | 0.00% |
| Net Debt / EBIDTA | -459.21% |
| Price To Book | 2.03 |
| Price Earnings Ratio | -73.41 |
| Price To FCF | 90.96 |
| Price To sales | 1.38 |
| EV / EBITDA | 58.74 |
News
- Jan -30 - Philips and leading dental practice network Tend collaborate to enhance patients' smiles with Philips Zoom! whitening portfolio
- Jan -29 - Philips signs agreement for sale of Emergency Care division
- Jan -29 - Philips jumps 160 spots on the Forbes 2025 "Canada’s Best Employers" list and gets a top spot in the Healthcare Equipment & Services Category
- Jan -28 - Sector Update: Health Care Stocks Softer Late Afternoon
- Jan -28 - Bridgefield Capital Enters into Definitive Agreement to Acquire Philips Emergency Care Business, Global Leader in Saving Lives
- Jan -28 - Philips to sell emergency care business
- Jan -14 - Philips recall of heart monitor software tied to 109 injuries, 2 deaths
- Jan -13 - Philips CEO sees subdued China sales this year
- Jan -09 - 5 smart home gadgets from CES
- Jan -09 - Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region
- Jan -08 - Philips divests chipmaking subsidiary Xiver to Dutch consortium
- Jan -07 - Philips sells small chipmaking subsidiary, Telegraaf reports
- Dec -20 - The 10 biggest medtech stories of 2024
- Dec -10 - NEFHSC, Baptist Health and Philips partner to offer pregnancy app subscription
- Dec -09 - Philips and SGH to launch MRI training centre in Singapore
- Dec -09 - NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App
- Dec -09 - Philips and Singapore General Hospital to advance medical imaging capabilities in Asia Pacific with first-of-its-kind MRI training collaboration
- Dec -04 - Philips is focused on a 'resilient and agile' supply chain: CEO
- Dec -03 - Philips aims to advance cardiac MRI technology through AI-driven research
- Dec -01 - Philips optimizes CT workflows with in-house AI, launches CT 5300 in North America at #RSNA2024
Business Breakdown
Expected Mid-Term Growth
Segment n°1 -> Diagnosis & Treatment
Expected Growth : 4.5 %
What the company do ?
Philips' Diagnosis & Treatment segment offers medical imaging systems, patient monitoring, and healthcare IT solutions to diagnose and treat diseases.
Why we expect these perspectives ?
Philips' Diagnosis & Treatment segment growth is driven by increasing demand for imaging systems and patient monitoring solutions, fueled by an aging population and rising healthcare expenditure. Additionally, the shift towards value-based care and precision medicine is boosting adoption of Philips' innovative solutions, such as AI-powered diagnostic tools and integrated healthcare platforms.
Segment n°2 -> Connected Care
Expected Growth : 4.8 %
What the company do ?
Connected Care from Koninklijke Philips N.V. is a healthcare technology platform that integrates data and analytics to provide personalized, patient-centered care.
Why we expect these perspectives ?
Philips' Connected Care segment growth is driven by increasing demand for remote patient monitoring, telehealth, and healthcare analytics. The COVID-19 pandemic has accelerated adoption of digital health technologies, while Philips' strategic partnerships and investments in AI-powered solutions have enhanced its offerings. Additionally, the growing need for cost-effective, patient-centric care and the increasing prevalence of chronic diseases are contributing to the segment's 4.8% growth.
Segment n°3 -> Personal Health
Expected Growth : 5.2 %
What the company do ?
Philips' Personal Health segment focuses on healthy living and prevention, offering solutions for healthy aging, mother and child care, and oral healthcare.
Why we expect these perspectives ?
Philips' Personal Health segment growth of 5.2% is driven by increasing consumer adoption of digital health technologies, rising demand for healthy living and wellness products, and expanding partnerships with healthcare providers. Additionally, the company's focus on innovation, such as AI-powered health monitoring solutions, and geographic expansion in high-growth markets also contribute to the segment's growth.
Segment n°4 -> Other
Expected Growth : 4.2 %
What the company do ?
The 'Other' segment from Koninklijke Philips N.V. includes results from its innovation activities, intellectual property, and group functions.
Why we expect these perspectives ?
Philips' 4.2% growth in 'Other' segment is driven by increasing demand for its sleep and respiratory care solutions, expansion in emerging markets, and strategic partnerships. Additionally, the company's focus on innovation, digital health technologies, and cost savings initiatives have contributed to this growth.
Koninklijke Philips N.V. Products
| Product Range | What is it ? |
|---|---|
| Personal Care | Philips offers a range of personal care products, including shavers, trimmers, and epilators for men and women. |
| Healthcare Informatics | Philips provides healthcare informatics solutions, including radiology, cardiology, and oncology information systems. |
| Diagnostic Imaging | Philips offers diagnostic imaging solutions, including MRI, CT, and ultrasound machines. |
| Patient Monitoring | Philips provides patient monitoring solutions, including bedside monitors and portable monitors. |
| Respiratory Care | Philips offers respiratory care solutions, including ventilators and oxygen therapy devices. |
| Sleep and Respiratory Care | Philips provides sleep and respiratory care solutions, including sleep apnea therapy devices. |
| Lighting | Philips offers a range of lighting solutions, including LED lighting, smart lighting, and lighting controls. |
| Home Healthcare | Philips provides home healthcare solutions, including telehealth and remote patient monitoring solutions. |
| Mother and Child Care | Philips offers mother and child care solutions, including maternal and fetal monitoring solutions. |
Koninklijke Philips N.V.'s Porter Forces
Threat Of Substitutes
Philips faces moderate threat from substitutes, as consumers have limited alternatives for its healthcare and consumer lifestyle products. However, the company's lighting business faces higher threat from substitutes, such as LED lighting from other manufacturers.
Bargaining Power Of Customers
Philips' customers have low bargaining power due to the company's strong brand presence and diversified product portfolio. Additionally, Philips' focus on innovation and quality helps to maintain customer loyalty.
Bargaining Power Of Suppliers
Philips' suppliers have moderate bargaining power due to the company's dependence on a few large suppliers for components and raw materials. However, Philips' strong relationships with suppliers and its diversified supply chain help to mitigate this risk.
Threat Of New Entrants
The threat of new entrants is low in Philips' industries, as high barriers to entry, such as significant capital investments and regulatory hurdles, discourage new competitors from entering the market.
Intensity Of Rivalry
The intensity of rivalry is high in Philips' industries, with established players competing fiercely for market share. The company faces intense competition from companies like GE Healthcare, Siemens Healthineers, and Samsung in the healthcare segment, and from companies like Samsung, LG, and Sony in the consumer electronics segment.
Capital Structure
| Value | |
|---|---|
| Debt Weight | 36.20% |
| Debt Cost | 4.33% |
| Equity Weight | 63.80% |
| Equity Cost | 7.41% |
| WACC | 6.29% |
| Leverage | 56.74% |
Koninklijke Philips N.V. : Quality Control
Koninklijke Philips N.V. passed 1 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
| Company | Rational |
|---|---|
| SNT.WA | Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and … |
| NOVO-B.CO | Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. … |
| GSK.L | GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the … |
| SOON.SW | Sonova Holding AG designs, develops, manufactures, and distributes hearing care solutions for adults and children. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The company offers wireless … |
| STE | STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning … |
Peers Metrics
DCF BETA
Expected Cash-Flows
Scoring Insights
Peers Group Analysis
🥇
GSK
A-Score
1-Year Total Return ->
🥈
Sonova
A-Score
1-Year Total Return ->
🥉
Novo Nordisk
A-Score
1-Year Total Return ->
4
Synektik
A-Score
1-Year Total Return ->
5
STERIS
A-Score
1-Year Total Return ->
6
